# Magnetic chitosan nanoparticle-exosome hydrogel enhances bladder function in diabetic bladder dysfunction via activating the FAK-p38 MAPK-GATA4 axis in adipose-derived mesenchymal stromal cells

**Authors:** Junhao Zheng, Daofeng Zhang, Haorui Li, Rongyang Jin, Hao Chen, Xiaoliang Sun, Haiyang Zhang

PMC · DOI: 10.1093/rb/rbag007 · Regenerative Biomaterials · 2026-01-29

## TL;DR

A magnetic hydrogel containing exosomes from treated cells improves bladder function in diabetic rats by promoting blood vessel and nerve growth.

## Contribution

A novel magnetic chitosan nanoparticle-exosome hydrogel is developed to treat diabetic bladder dysfunction by activating specific cellular pathways.

## Key findings

- DLSW activates the FAK-p38 MAPK-GATA4 axis in ADSCs, increasing VEGF and NGF secretion.
- The magnetic CSNP-Exo hydrogel effectively targets and improves bladder function in diabetic rats.
- Exosome-mediated GATA4 upregulation enhances vascular and neural repair in bladder tissue.

## Abstract

Previous attempts to combine adipose-derived mesenchymal stromal cells (ADSCs) with defocused low-energy shock wave (DLSW) have shown effectiveness in treating diabetic bladder dysfunction (DBD). However, the specific mechanisms underlying their therapeutic effects and strategies to enhance the colonization of ADSCs at the disease site remain challenging. Hereby, our investigation revealed that DLSW activated the FAK-p38 MAPK-GATA4 axis in ADSCs, resulting in enhanced secretion of vascular endothelial growth factor (VEGF) and nerve growth factor (NGF). Moreover, tube formation assay and major pelvic ganglia culture showed that the effects of VEGF and NGF on angiogenesis and nerve fiber growth were hindered by adding GATA4 inhibitors. We developed a thermosensitive hydrogel using chitosan nanoparticles (CSNP) incorporated with β-glycerophosphate and Fe3O4, and loaded it with exosomes (Exo) derived from DLSW-pretreated ADSCs to create a magnetic CSNP-Exo hydrogel. This hydrogel displayed favorable targeting ability, swelling properties, and sustained release profiles. In animal experiments, a DBD rat model was established by feeding a high-fat diet and injecting streptozotocin. Conscious cystometry results showed that the CSNP-Exo hydrogel ameliorated voiding function. Histological examinations revealed that CSNP-Exo hydrogel exhibited prolonged retention in the bladder and facilitated the expression of VEGF and NGF in damaged bladder tissues through Exo-mediated upregulation of GATA4. Correspondingly, staining results showed that vascular formation and neural repair in the bladder tissue were also significantly accelerated. Thus, magnetic CSNP-Exo hydrogel holds promising potential for the treatment of DBD.

## Linked entities

- **Genes:** PTK2 (protein tyrosine kinase 2) [NCBI Gene 5747], P38mapk (p38 map kinase) [NCBI Gene 692545], GATA4 (GATA binding protein 4) [NCBI Gene 2626]
- **Proteins:** VEGFA (vascular endothelial growth factor A), NGF (nerve growth factor)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Ptk2 (protein tyrosine kinase 2) [NCBI Gene 25614] {aka FAK, FRNK, p125FAK}, Ptprc (protein tyrosine phosphatase, receptor type, C) [NCBI Gene 24699] {aka CD45, L-CA, Lca, RT7, T200}, Fgf2 (fibroblast growth factor 2) [NCBI Gene 54250] {aka Fgf-2, Fgf2a, bFGF}, Igf1 (insulin-like growth factor 1) [NCBI Gene 24482] {aka IGF}, Ephb1 (Eph receptor B1) [NCBI Gene 24338] {aka Ephb2, Erk, elk}, Mapk8 (mitogen-activated protein kinase 8) [NCBI Gene 116554] {aka JNK}, Cd81 (Cd81 molecule) [NCBI Gene 25621] {aka Tapa1}, Pik3cg (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma) [NCBI Gene 298947] {aka Pi3k}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 24383] {aka BARS-38, Gapd}, Thy1 (Thy-1 cell surface antigen) [NCBI Gene 24832] {aka CD7}, Mapk14 (mitogen activated protein kinase 14) [NCBI Gene 81649] {aka CRK1, CSBP, CSPB1, Csbp1, Csbp2, Exip}, Cd34 (CD34 molecule) [NCBI Gene 305081], Bdnf (brain-derived neurotrophic factor) [NCBI Gene 24225], PTK2 (protein tyrosine kinase 2) [NCBI Gene 5747] {aka FADK, FADK 1, FAK, FAK1, FRNK, PPP1R71}, Socs1 (suppressor of cytokine signaling 1) [NCBI Gene 252971] {aka Cish1, Socs-1}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 83785] {aka VEGF-A, VEGF111, VEGF164, VPF, Vegf}, Akt1 (AKT serine/threonine kinase 1) [NCBI Gene 24185] {aka Akt}, Cd44 (CD44 molecule) [NCBI Gene 25406] {aka CD44A, METAA, RHAMM}, GATA4 (GATA binding protein 4) [NCBI Gene 2626] {aka ASD2, TACHD, TOF, VSD1}, Stmn4 (stathmin 4) [NCBI Gene 79423] {aka Lagl, Rb3}, Cd63 (Cd63 molecule) [NCBI Gene 29186], Hgf (hepatocyte growth factor) [NCBI Gene 24446] {aka HPTA}, Wnt2 (Wnt family member 2) [NCBI Gene 114487] {aka Wnt}, Gata4 (GATA binding protein 4) [NCBI Gene 54254], Ngf (nerve growth factor) [NCBI Gene 310738] {aka Ngfb, beta-NGF}
- **Diseases:** fibrosis (MESH:D005355), bladder inflammation (MESH:D007249), wounds (MESH:D014947), DLSW (MESH:D012769), diabetes mellitus (MESH:D003920), vasculopathy (MESH:D000090122), detrusor atrophy (MESH:D001284), voiding abnormalities (MESH:C537271), swelling (MESH:D004487), spinal cord injury (MESH:D013119), DBD (MESH:D001745), nerve injuries (MESH:D000080902), erectile dysfunction (MESH:D007172), incontinence (MESH:D014549), neuropathy (MESH:D009422)
- **Chemicals:** paraffin (MESH:D010232), fat (MESH:D005223), Phalloidin (MESH:D010590), CS (MESH:D048271), nitrogen (MESH:D009584), NH4Cl (MESH:D000643), mineral oil (MESH:D008899), FITC (MESH:D016650), polysaccharide (MESH:D011134), polymer (MESH:D011108), streptomycin (MESH:D013307), SB203580 (MESH:C093642), water (MESH:D014867), STZ (MESH:D013311), hydrochloric acid (MESH:D006851), blood glucose (MESH:D001786), polyethylene (MESH:D020959), halothane (MESH:D006221), BI 853520 (-), penicillin (MESH:D010406), fungizone (MESH:D000666), beta-glycerophosphate (MESH:C031463), PKH26 (MESH:C070080), polystyrene (MESH:D011137), CO2 (MESH:D002245), paraformaldehyde (MESH:C003043), lipid (MESH:D008055), hydrogen (MESH:D006859), Texas Red (MESH:C034657), 4',6-diamidino-2-phenylindole (MESH:C007293), formaldehyde (MESH:D005557), glucose (MESH:D005947)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12952527/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12952527/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC12952527/full.md

---
Source: https://tomesphere.com/paper/PMC12952527